CHMA Trims Workforce, INFI's DYNAMO Disappoints, Marathon Joins DMD Race

Privately held Marathon Pharmaceuticals LLC has submitted a New Drug Application to the FDA for Deflazacort, an investigational Duchenne Muscular Dystrophy drug.

from RTT - Biotech http://ift.tt/1UtMge2
via IFTTT